𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The effect of age on the pharmacokinetics of valsartan

✍ Scribed by A. Sioufi; F. Marfil; A. Jaouen; J. M. Cardot; J. Godbillon; F. Ezzet; P. Lloyd


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
162 KB
Volume
19
Category
Article
ISSN
0142-2782

No coin nor oath required. For personal study only.

✦ Synopsis


Twelve young (mean age 23 years, range 18-28) and 12 elderly (mean age 76 years, range 65-89) volunteers were given a single oral dose of 80 mg valsartan after an overnight fast. Each group consisted of six male and six female subjects. Mean systemic exposure to valsartan was higher in the elderly when compared with the young (AUC(0-24 h), 52% increase and AUC(0-infinity), 70% increase). Variability, as shown by the coefficient of variation (CV), was larger for the elderly subjects and ANOVA of the log transformed AUC showed a significant difference between the two groups. This difference was largely brought about by five elderly subjects (one male, four females), whose AUC was about 2-fold higher than the rest of the group. For the remaining elderly subjects, plasma valsartan AUC was similar to that observed for the young volunteers. This higher systemic exposure in five of the elderly subjects is not thought to be of clinical relevance when data from the patient population are considered. Other covariates--such as body weight, comedication, creatinine clearance, valsartan kinetics (absorption rate, distribution, and elimination)--did not explain the higher AUC in this subset of the elderly group. Data from the present study were compared with population kinetic data obtained from larger clinical trials including hypertensive patients in all age groups. Using this population approach, there was no difference in the pharmacokinetics of valsartan between male and female patients. Also, a relationship between plasma clearance of valsartan and age was established. The median age of patients in the hypertensive pool was 55 years. For an average 70-year-old patient, plasma clearance of valsartan is predicted to fall by 22% compared with an average 55-year-old. For the population this difference is not sufficient to warrant initial dose adjustment based on age per se. The covariate age, does not completely explain the variability in the pharmacokinetics of valsartan within the general population. The treatment was well tolerated.


πŸ“œ SIMILAR VOLUMES


Evaluation of the effect of food on the
✍ P. H. Marathe; D. S. Greene; G. D. Kollia; R. H. Barbhaiya πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 272 KB πŸ‘ 2 views

Bioavailability of avitriptan was found to decrease significantly when administered 5 min after a standard high fat meal. The studies described herein were carried out to gain insight into the mechanism of this food effect. A series of studies were conducted in humans to assess the effect of timing

THE EFFECT OF FOOD ON THE PHARMACOKINETI
✍ I. D. COCKSHOTT; S. D. OLIVER; J. J. YOUNG; K. J. COOPER; D. C. JONES πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 132 KB πŸ‘ 1 views

Casodex' (bicalutamide) is an orally active, non-steroidal, pure antiandrogen; it is a racemate with antiandrogenic activity residing predominantly in the (R)-enantiomer. Healthy male volunteers (n=15) were administered single oral doses of bicalutamide (50 mg) after food and after fasting as part o

The effect of exercise on pharmacokineti
✍ I. Reuter; S. Harder; M. Engelhardt; H. Baas πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 135 KB

The aim of our study was to evaluate the influence of low-intensity exercise on levodopa absorption and levodopa motor effect. We studied the pharmacokinetics and pharmacodynamics of levodopa under resting conditions and under a workload of 50 watts for 2 hours on a cycle ergometer in 12 parkinsonia

Effect of itraconazole on the pharmacoki
✍ Kazuyo Nishihara; Junko Hibino; Hajime Kotaki; Yasufumi Sawada; Tatsuji Iga πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 129 KB πŸ‘ 1 views

The effect of itraconazole (ITZ) on the pharmacokinetics of digoxin (DGX) was investigated in guinea pigs. The plasma concentrations of DGX in guinea pigs following treatment with ITZ (20 mg/kg intraperitoneally (i.p.)) after intravenous (i.v.) administration of DGX (0.125 mg/kg) were significantly

No effect of chloroquine on theophylline
✍ Bedassa A. Motti; Michael Ashton πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 120 KB πŸ‘ 1 views

The immediate and delayed effects of chloroquine on theophylline kinetics were investigated in rats pretreated with chloroquine diphosphate (45 mg kg -1 ) or saline intraperitoneally. One hour or 4 days after chloroquine, theophylline (10 mg kg -1 ) was administered intravenously. Compared with the

Effect of age on CSF metabolites
✍ Robert A. Fishman πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 121 KB